Prophylactic and theraputic treatment of group A streptococcal infection
US5985271A · kind A · utility
51Cited by
2References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 25, 1999 |
| Grant date | Nov 16, 1999 |
| Priority date | — |
| Expiry date | Feb 25, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y302/01017
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to an oral delivery system containing a group c streptococcal phage associated lysin enzyme for the prophylactic and therapeutic treatment of Streptococcal A throat infections, commonly known as strep throat.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.